FDA Opposes COVID-19 Vaccination Dose and Schedule Changes to Vaccinate More People

FDA Opposes COVID-19 Vaccination Dose and Schedule Changes to Vaccinate More People

Only two weeks after the first experimental biologic for SARS-CoV-2 became available, the U.S. was more than 16 millions doses behind Operation Warp Speed’s goal of giving COVID-19 vaccines to 20 million people by the end of 2020.1 Responding to the slow rollout, Operation Warp Speed chief adviser Moncef Slaoui, MD proposed giving half-doses to […]

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]

Former FDA Commissioner Gottlieb Joins Pfizer

Former FDA Commissioner Gottlieb Joins Pfizer

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD has joined the board of directors of Pfizer, Inc.—the world’s largest pharmaceutical company and second largest manufacturer of vaccines. Pfizer, which posted total revenues of $53.7 billion in 2018, announced Dr. Gottlieb’s election to the board on June 27, 2019.1 2 3 4 Dr. Gottlieb, […]